Use 780.2 when patients faint after Gardasil vaccine

Why This Topic Matters

It helps practices understand how to capture the vaccination encounter and any separately identifiable evaluation that follows a fainting episode, while staying aware of related diagnosis coding and documentation considerations.

Article Sections

1. Post-vaccination fainting and follow-up evaluation

   Covers the scenario in which a patient faints after a vaccination and receives additional evaluation afterward. The section focuses on the general billing context for that follow-up care.

2. Diagnosis coding discussion

   Addresses the diagnosis coding approach discussed for the fainting episode and contrasts it with an alternative diagnosis category mentioned in the article.

3. FDA label update and observation reminder

   Summarizes the article’s discussion of labeling changes, reported fainting-related observations, and the post-vaccination monitoring reminder.

4. Vaccine, administration, and well-visit reporting

   Lists the broad reporting categories covered for the vaccine product, administration service, and age-based preventive visit codes.

5. Cost and billing perspective

   Includes commentary on whether practices may choose to bill the additional evaluation and the patient-facing implications of that choice.